![]() MetaStat MetaStat, Inc. develops and commercializes diagnostic tests for risk of cancer metastasis, companion diagnostics and anti-metastatic drugs. | ![]() Salarius Pharmaceuticals Salarius Pharmaceuticals is a clinical-stage biotechnology company developing epigenetic-based cancer treatments. | ![]() Immutep Immutep (formerly Prima BioMed) is a biotechnology company focused on developing autoimmune and cancer immunotherapy treatment. | ![]() Bexion Pharmaceuticals Bexion Pharmaceuticals is a company committed to the discovery, clinical development, and acquisition of oncology treatments. | Bold Therapeutics Bold Therapeutics is a biotechnology company developing cancer therapy for the treatment of gastric, pancreatic, colorectal, and other cancers. | |
Founding Date | Founding Date 2010 | Founding Date 2011 | Founding Date 2001 | Founding Date 2006 | Founding Date 2018 |
Type | Type Public | Type Public | Type Public | Type Private | Type Private |
Tags | |||||
Locations | Locations Boston, US HQ | Locations Houston, US HQ | Locations Sydney, AU HQ Sydney, AU The Rocks, AU Orsay, FR Berlin, DE Leipzig, DE | Locations Covington, US HQ | Locations Vancouver, CA HQ |
Employees | Employees 6 | Employees 2 | Employees 2427% decrease | Employees 274% increase | Employees 205% increase |
Valuation ($) | Valuation ($) 20.6 k | Valuation ($) 2.4 m | Valuation ($) 282.4 m | Valuation ($) N/A | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) $23.3k (FY, 2018) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) N/A |
Net income | Net income ($3.2m) (FY, 2018) | Net income N/A | Net income ($61.4m) (FY, 2025) | Net income N/A | Net income N/A |
Funding | |||||
Total funding raised | Total funding raised $ 350k | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 16.6m | Total funding raised N/A |

Salarius Pharmaceuticals is a clinical-stage biotechnology company developing epigenetic-based cancer treatments.
View company
Immutep (formerly Prima BioMed) is a biotechnology company focused on developing autoimmune and cancer immunotherapy treatment.
View company
Bexion Pharmaceuticals is a company committed to the discovery, clinical development, and acquisition of oncology treatments.
View companyBold Therapeutics is a biotechnology company developing cancer therapy for the treatment of gastric, pancreatic, colorectal, and other cancers.
View company